DDAVP - 0075-2451-53 - (desmopressin acetate)

Alphabetical Index


Drug Information of DDAVP

Product NDC: 0075-2451
Proprietary Name: DDAVP
Non Proprietary Name: desmopressin acetate
Active Ingredient(s): 4    ug/mL & nbsp;   desmopressin acetate
Administration Route(s): INTRAVENOUS
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of DDAVP

Product NDC: 0075-2451
Labeler Name: sanofi-aventis U.S. LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018938
Marketing Category: NDA
Start Marketing Date: 19840330

Package Information of DDAVP

Package NDC: 0075-2451-53
Package Description: 1 VIAL, MULTI-DOSE in 1 CARTON (0075-2451-53) > 10 mL in 1 VIAL, MULTI-DOSE

NDC Information of DDAVP

NDC Code 0075-2451-53
Proprietary Name DDAVP
Package Description 1 VIAL, MULTI-DOSE in 1 CARTON (0075-2451-53) > 10 mL in 1 VIAL, MULTI-DOSE
Product NDC 0075-2451
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name desmopressin acetate
Dosage Form Name SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19840330
Marketing Category Name NDA
Labeler Name sanofi-aventis U.S. LLC
Substance Name DESMOPRESSIN ACETATE
Strength Number 4
Strength Unit ug/mL
Pharmaceutical Classes Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient]

Complete Information of DDAVP


General Information